Logo image of CX

CEMEX SAB-SPONS ADR PART CER (CX) Stock Fundamental Analysis

NYSE:CX - New York Stock Exchange, Inc. - US1512908898 - ADR - Currency: USD

5.92  +0.23 (+4.04%)

After market: 5.93 +0.01 (+0.17%)

Fundamental Rating

4

Taking everything into account, CX scores 4 out of 10 in our fundamental rating. CX was compared to 12 industry peers in the Construction Materials industry. While CX is still in line with the averages on profitability rating, there are concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on CX.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CX was profitable.
In the past year CX had a positive cash flow from operations.
CX had positive earnings in 4 of the past 5 years.
Each year in the past 5 years CX had a positive operating cash flow.
CX Yearly Net Income VS EBIT VS OCF VS FCFCX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B 2B

1.2 Ratios

CX has a Return On Assets of 4.37%. This is amonst the worse of the industry: CX underperforms 91.67% of its industry peers.
CX has a worse Return On Equity (9.80%) than 91.67% of its industry peers.
The Return On Invested Capital of CX (8.41%) is worse than 66.67% of its industry peers.
CX had an Average Return On Invested Capital over the past 3 years of 6.80%. This is significantly below the industry average of 20.02%.
The 3 year average ROIC (6.80%) for CX is below the current ROIC(8.41%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.37%
ROE 9.8%
ROIC 8.41%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.38%
ROIC(3y)6.8%
ROIC(5y)6.29%
CX Yearly ROA, ROE, ROICCX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 -10 -15

1.3 Margins

With a Profit Margin value of 5.89%, CX is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of CX has grown nicely.
The Operating Margin of CX (11.14%) is worse than 83.33% of its industry peers.
In the last couple of years the Operating Margin of CX has grown nicely.
CX has a Gross Margin of 33.63%. This is in the better half of the industry: CX outperforms 75.00% of its industry peers.
CX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.14%
PM (TTM) 5.89%
GM 33.63%
OM growth 3Y-2.04%
OM growth 5Y2.13%
PM growth 3Y3.43%
PM growth 5Y39.7%
GM growth 3Y1.36%
GM growth 5Y0.48%
CX Yearly Profit, Operating, Gross MarginsCX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

1

2. Health

2.1 Basic Checks

CX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The debt/assets ratio for CX has been reduced compared to a year ago.
CX Yearly Shares OutstandingCX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B
CX Yearly Total Debt VS Total AssetsCX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CX has an Altman-Z score of 1.56. This is a bad value and indicates that CX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of CX (1.56) is worse than 75.00% of its industry peers.
The Debt to FCF ratio of CX is 13.83, which is on the high side as it means it would take CX, 13.83 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 13.83, CX is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
CX has a Debt/Equity ratio of 0.51. This is a neutral value indicating CX is somewhat dependend on debt financing.
CX's Debt to Equity ratio of 0.51 is in line compared to the rest of the industry. CX outperforms 58.33% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 13.83
Altman-Z 1.56
ROIC/WACC0.73
WACC11.45%
CX Yearly LT Debt VS Equity VS FCFCX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CX has a Current Ratio of 0.82. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
CX has a worse Current ratio (0.82) than 91.67% of its industry peers.
CX has a Quick Ratio of 0.82. This is a bad value and indicates that CX is not financially healthy enough and could expect problems in meeting its short term obligations.
CX's Quick ratio of 0.58 is on the low side compared to the rest of the industry. CX is outperformed by 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.58
CX Yearly Current Assets VS Current LiabilitesCX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

5

3. Growth

3.1 Past

CX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 914.72%, which is quite impressive.
The Earnings Per Share has been growing by 76.41% on average over the past years. This is a very strong growth
CX shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.36%.
CX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)914.72%
EPS 3Y-35.5%
EPS 5Y76.41%
EPS Q2Q%130%
Revenue 1Y (TTM)16.36%
Revenue growth 3Y4.06%
Revenue growth 5Y4.29%
Sales Q2Q%-10.18%

3.2 Future

CX is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -18.89% yearly.
The Revenue is expected to grow by 4.14% on average over the next years.
EPS Next Y-64.42%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue Next Year-0.35%
Revenue Next 2Y2.6%
Revenue Next 3Y2.9%
Revenue Next 5Y4.14%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CX Yearly Revenue VS EstimatesCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50B 100B 150B 200B 250B
CX Yearly EPS VS EstimatesCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 20 -20 -40 -60

7

4. Valuation

4.1 Price/Earnings Ratio

CX is valuated cheaply with a Price/Earnings ratio of 1.02.
CX's Price/Earnings ratio is rather cheap when compared to the industry. CX is cheaper than 91.67% of the companies in the same industry.
CX's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.79.
CX is valuated cheaply with a Price/Forward Earnings ratio of 2.87.
Based on the Price/Forward Earnings ratio, CX is valued cheaper than 100.00% of the companies in the same industry.
CX's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.38.
Industry RankSector Rank
PE 1.02
Fwd PE 2.87
CX Price Earnings VS Forward Price EarningsCX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CX indicates a rather cheap valuation: CX is cheaper than 91.67% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CX is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 17.73
EV/EBITDA 3.9
CX Per share dataCX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CX's earnings are expected to decrease with -18.89% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)0.01
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%

6

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 45.93%, CX is a good candidate for dividend investing.
CX's Dividend Yield is rather good when compared to the industry average which is at 7.42. CX pays more dividend than 100.00% of the companies in the same industry.
CX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.51.
Industry RankSector Rank
Dividend Yield 45.93%

5.2 History

CX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CX Yearly Dividends per shareCX Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

CX pays out 7.49% of its income as dividend. This is a sustainable payout ratio.
DP7.49%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
CX Yearly Income VS Free CF VS DividendCX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B -1B
CX Dividend Payout.CX Dividend Payout, showing the Payout Ratio.CX Dividend Payout.PayoutRetained Earnings

CEMEX SAB-SPONS ADR PART CER

NYSE:CX (4/25/2025, 8:04:00 PM)

After market: 5.93 +0.01 (+0.17%)

5.92

+0.23 (+4.04%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-06 2025-02-06/bmo
Earnings (Next)04-28 2025-04-28
Inst Owners26.76%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap8.59B
Analysts80
Price Target5.93 (0.17%)
Short Float %1.24%
Short Ratio1.29
Dividend
Industry RankSector Rank
Dividend Yield 45.93%
Yearly Dividend0
Dividend Growth(5Y)N/A
DP7.49%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-10 2025-03-10 (0.02067)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-61.81%
Min EPS beat(2)-88.35%
Max EPS beat(2)-35.28%
EPS beat(4)1
Avg EPS beat(4)343.85%
Min EPS beat(4)-88.35%
Max EPS beat(4)1550.49%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-6.59%
Min Revenue beat(2)-8.32%
Max Revenue beat(2)-4.86%
Revenue beat(4)0
Avg Revenue beat(4)-5.42%
Min Revenue beat(4)-8.32%
Max Revenue beat(4)-2%
Revenue beat(8)1
Avg Revenue beat(8)-3.36%
Revenue beat(12)2
Avg Revenue beat(12)3.78%
Revenue beat(16)2
Avg Revenue beat(16)-9.89%
PT rev (1m)-8.42%
PT rev (3m)-0.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-9.08%
EPS NY rev (3m)-9.08%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-9.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)11.71%
Valuation
Industry RankSector Rank
PE 1.02
Fwd PE 2.87
P/S 0.42
P/FCF 17.73
P/OCF 4.53
P/B 0.71
P/tB 3.05
EV/EBITDA 3.9
EPS(TTM)5.79
EY97.8%
EPS(NY)2.06
Fwd EY34.8%
FCF(TTM)0.33
FCFY5.64%
OCF(TTM)1.31
OCFY22.06%
SpS13.97
BVpS8.39
TBVpS1.94
PEG (NY)N/A
PEG (5Y)0.01
Profitability
Industry RankSector Rank
ROA 4.37%
ROE 9.8%
ROCE 10.65%
ROIC 8.41%
ROICexc 8.86%
ROICexgc 16.56%
OM 11.14%
PM (TTM) 5.89%
GM 33.63%
FCFM 2.39%
ROA(3y)2.44%
ROA(5y)0.96%
ROE(3y)5.81%
ROE(5y)1.38%
ROIC(3y)6.8%
ROIC(5y)6.29%
ROICexc(3y)7.1%
ROICexc(5y)6.57%
ROICexgc(3y)13.19%
ROICexgc(5y)12.35%
ROCE(3y)8.61%
ROCE(5y)7.97%
ROICexcg growth 3Y1.72%
ROICexcg growth 5Y7.8%
ROICexc growth 3Y2.49%
ROICexc growth 5Y9.41%
OM growth 3Y-2.04%
OM growth 5Y2.13%
PM growth 3Y3.43%
PM growth 5Y39.7%
GM growth 3Y1.36%
GM growth 5Y0.48%
F-Score7
Asset Turnover0.74
Health
Industry RankSector Rank
Debt/Equity 0.51
Debt/FCF 13.83
Debt/EBITDA 1.78
Cap/Depr 112.7%
Cap/Sales 6.96%
Interest Coverage 250
Cash Conversion 53.98%
Profit Quality 40.6%
Current Ratio 0.82
Quick Ratio 0.58
Altman-Z 1.56
F-Score7
WACC11.45%
ROIC/WACC0.73
Cap/Depr(3y)101.24%
Cap/Depr(5y)88.82%
Cap/Sales(3y)7.45%
Cap/Sales(5y)6.75%
Profit Quality(3y)213.08%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)914.72%
EPS 3Y-35.5%
EPS 5Y76.41%
EPS Q2Q%130%
EPS Next Y-64.42%
EPS Next 2Y-26.95%
EPS Next 3Y-18.89%
EPS Next 5YN/A
Revenue 1Y (TTM)16.36%
Revenue growth 3Y4.06%
Revenue growth 5Y4.29%
Sales Q2Q%-10.18%
Revenue Next Year-0.35%
Revenue Next 2Y2.6%
Revenue Next 3Y2.9%
Revenue Next 5Y4.14%
EBIT growth 1Y22.13%
EBIT growth 3Y1.93%
EBIT growth 5Y6.51%
EBIT Next Year62.29%
EBIT Next 3Y20.65%
EBIT Next 5YN/A
FCF growth 1Y-50.77%
FCF growth 3Y-17.57%
FCF growth 5Y-7.15%
OCF growth 1Y-12.26%
OCF growth 3Y0.92%
OCF growth 5Y6.96%